Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study

Abstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four si...

Full description

Bibliographic Details
Main Authors: Daniel DiCenzo, Karina Quiaoit, Kashuf Fatima, Divya Bhardwaj, Lakshmanan Sannachi, Mehrdad Gangeh, Ali Sadeghi‐Naini, Archya Dasgupta, Michael C. Kolios, Maureen Trudeau, Sonal Gandhi, Andrea Eisen, Frances Wright, Nicole Look Hong, Arjun Sahgal, Greg Stanisz, Christine Brezden, Robert Dinniwell, William T. Tran, Wei Yang, Belinda Curpen, Gregory J. Czarnota
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.3255
id doaj-459aa443dbf64da88da60748573933db
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Daniel DiCenzo
Karina Quiaoit
Kashuf Fatima
Divya Bhardwaj
Lakshmanan Sannachi
Mehrdad Gangeh
Ali Sadeghi‐Naini
Archya Dasgupta
Michael C. Kolios
Maureen Trudeau
Sonal Gandhi
Andrea Eisen
Frances Wright
Nicole Look Hong
Arjun Sahgal
Greg Stanisz
Christine Brezden
Robert Dinniwell
William T. Tran
Wei Yang
Belinda Curpen
Gregory J. Czarnota
spellingShingle Daniel DiCenzo
Karina Quiaoit
Kashuf Fatima
Divya Bhardwaj
Lakshmanan Sannachi
Mehrdad Gangeh
Ali Sadeghi‐Naini
Archya Dasgupta
Michael C. Kolios
Maureen Trudeau
Sonal Gandhi
Andrea Eisen
Frances Wright
Nicole Look Hong
Arjun Sahgal
Greg Stanisz
Christine Brezden
Robert Dinniwell
William T. Tran
Wei Yang
Belinda Curpen
Gregory J. Czarnota
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
Cancer Medicine
imaging biomarker
locally advanced breast cancer
machine learning
neoadjuvant chemotherapy
quantitative ultrasound
radiomics
author_facet Daniel DiCenzo
Karina Quiaoit
Kashuf Fatima
Divya Bhardwaj
Lakshmanan Sannachi
Mehrdad Gangeh
Ali Sadeghi‐Naini
Archya Dasgupta
Michael C. Kolios
Maureen Trudeau
Sonal Gandhi
Andrea Eisen
Frances Wright
Nicole Look Hong
Arjun Sahgal
Greg Stanisz
Christine Brezden
Robert Dinniwell
William T. Tran
Wei Yang
Belinda Curpen
Gregory J. Czarnota
author_sort Daniel DiCenzo
title Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
title_short Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
title_full Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
title_fullStr Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
title_full_unstemmed Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
title_sort quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: results from multi‐institutional study
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2020-08-01
description Abstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four sites across North America, and appropriate approval was obtained from the individual ethics committees. Eighty‐two patients with LABC were included for final analysis. Primary tumors were scanned using a clinical ultrasound system before NAC was started. The tumors were contoured, and radiofrequency data were acquired and processed from whole tumor regions of interest. QUS spectral parameters were derived from the normalized power spectrum, and texture analysis was performed based on six QUS features using a gray level co‐occurrence matrix. Patients were divided into responder or nonresponder classes based on their clinical‐pathological response. Classification analysis was performed using machine learning algorithms, which were trained to optimize classification accuracy. Cross‐validation was performed using a leave‐one‐out cross‐validation method. Results Based on the clinical outcomes of NAC treatment, there were 48 responders and 34 nonresponders. A K‐nearest neighbors (K‐NN) approach resulted in the best classifier performance, with a sensitivity of 91%, a specificity of 83%, and an accuracy of 87%. Conclusion QUS‐based radiomics can predict response to NAC based on pretreatment features with acceptable accuracy.
topic imaging biomarker
locally advanced breast cancer
machine learning
neoadjuvant chemotherapy
quantitative ultrasound
radiomics
url https://doi.org/10.1002/cam4.3255
work_keys_str_mv AT danieldicenzo quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT karinaquiaoit quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT kashuffatima quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT divyabhardwaj quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT lakshmanansannachi quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT mehrdadgangeh quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT alisadeghinaini quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT archyadasgupta quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT michaelckolios quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT maureentrudeau quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT sonalgandhi quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT andreaeisen quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT franceswright quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT nicolelookhong quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT arjunsahgal quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT gregstanisz quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT christinebrezden quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT robertdinniwell quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT williamttran quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT weiyang quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT belindacurpen quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
AT gregoryjczarnota quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy
_version_ 1724630992763748352
spelling doaj-459aa443dbf64da88da60748573933db2020-11-25T03:17:37ZengWileyCancer Medicine2045-76342020-08-019165798580610.1002/cam4.3255Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional studyDaniel DiCenzo0Karina Quiaoit1Kashuf Fatima2Divya Bhardwaj3Lakshmanan Sannachi4Mehrdad Gangeh5Ali Sadeghi‐Naini6Archya Dasgupta7Michael C. Kolios8Maureen Trudeau9Sonal Gandhi10Andrea Eisen11Frances Wright12Nicole Look Hong13Arjun Sahgal14Greg Stanisz15Christine Brezden16Robert Dinniwell17William T. Tran18Wei Yang19Belinda Curpen20Gregory J. Czarnota21Department of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Physics Ryerson University Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaSurgical Oncology Department of Surgery Sunnybrook Health Sciences Centre Toronto ON CanadaSurgical Oncology Department of Surgery Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaPhysical Sciences Sunnybrook Research Institute Toronto ON CanadaMedical Oncology Saint Michael's HospitalUniversity of Toronto Toronto ON CanadaDepartment of Radiation Oncology Princess Margaret HospitalUniversity Health Network Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Diagnostic Radiology University of Texas Houston TX USADepartment of Medical Imaging Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaAbstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four sites across North America, and appropriate approval was obtained from the individual ethics committees. Eighty‐two patients with LABC were included for final analysis. Primary tumors were scanned using a clinical ultrasound system before NAC was started. The tumors were contoured, and radiofrequency data were acquired and processed from whole tumor regions of interest. QUS spectral parameters were derived from the normalized power spectrum, and texture analysis was performed based on six QUS features using a gray level co‐occurrence matrix. Patients were divided into responder or nonresponder classes based on their clinical‐pathological response. Classification analysis was performed using machine learning algorithms, which were trained to optimize classification accuracy. Cross‐validation was performed using a leave‐one‐out cross‐validation method. Results Based on the clinical outcomes of NAC treatment, there were 48 responders and 34 nonresponders. A K‐nearest neighbors (K‐NN) approach resulted in the best classifier performance, with a sensitivity of 91%, a specificity of 83%, and an accuracy of 87%. Conclusion QUS‐based radiomics can predict response to NAC based on pretreatment features with acceptable accuracy.https://doi.org/10.1002/cam4.3255imaging biomarkerlocally advanced breast cancermachine learningneoadjuvant chemotherapyquantitative ultrasoundradiomics